SNQ – Symbol of National Quality

SNQ is built on evidence-based standards, setting trusted quality and safety benchmarks for healthcare, biomedical, health, and animal care services and products.

  • 9F, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City, Taiwan
  • +886 2 2655 7888
  • snq@snq.com.tw

About

  • Vision & Mission
  • Review Committee
  • Certification Schedule

Application

  • Medical Service
  • Biomedical Product
  • Health Product
  • Animal Care & Products

SNQ Certified

  • Certified Services & Products
  • Certified Organizations
  • Quality Award Winners

International Certification

  • ICHOM PROMs
  • NSF Certification

Quality Insights

  • Apply for Certification →
Organized by|Research Center for Biotechnology and Medicine PolicyOperated by|Broadway International Standards Co., Ltd.© 2026 Broadway International Standards Co., Ltd. All rights reserved.Privacy Policy
SNQ – Symbol of National Quality
繁中
/
EN

Target Population

Acute coronary syndrome patients


Description

To utilize skin sympathetic nerve activity (SKNA) measurement for the precise risk assessment of arrhythmias and major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS), thereby applying SKNA as a monitoring and predictive tool for high-risk populations.


Key Highlights

Skin sympathetic nerve activity (SKNA) represents a featured, non-invasive medical technology at KMUH, demonstrating broad applicability in diseases associated with high sympathetic tone.

The integration of artificial intelligence approaches, including frequency-domain analysis and machine learning, for the prediction of MACE is a globally pioneering and highly innovative breakthrough.

Service Data

Our Coronary Care Unit (CCU) handles an annual admission volume of over 500 patients and has successfully screened more than 100 individuals. By integrating artificial intelligence models, SKNA demonstrates a predictive accuracy of over 80% for acute coronary syndrome (ACS).


Featured Outcomes

SKNA is elevated in acute coronary syndrome (ACS) and is significantly associated with ventricular tachycardia (VT).

In patients presenting with syncope, SKNA can be utilized to predict the presence of autonomic-related vasovagal syncope (VVS).

For patients with esophageal cancer, SKNA can serve as a predictive tool for post-treatment prognosis.

SKNA acts as a highly promising potential biomarker for overactive bladder (OAB).

To date, there are 36 SKNA-related publications globally searchable on PubMed. Kaohsiung Medical University Hospital (KMUH) has contributed to 5 of these, ranking first domestically and second worldwide—surpassed only by the inventor of SKNA, Professor Peng-Sheng Chen.


Safety Outcomes

Enhanced Safety -- The prediction of arrhythmias and MACE in high-risk populations allows for proactive clinical management, significantly improving patient safety and care outcomes.


Satisfaction

Patient Satisfaction -- Mitigating the occurrence of arrhythmias and MACE effectively improves clinical outcomes, thereby elevating the overall patient experience and satisfaction.


International Achievements

HRS 2018 – Abstract Presentation

HRS 2019 – Abstract Presentation

APHRS 2019 – Invited Speaker

KHRS 2020 – Invited Speaker

KHRS 2021 – Invited Speaker

KHRS 2022 – Invited Speaker


Benefits and Impacts

Quality of Care -- Reducing the incidence of arrhythmias and MACE effectively improves clinical outcomes, thereby enhancing the overall quality of healthcare services.

By employing SKNA as a non-invasive, streamlined, and innovative approach for the precise evaluation of sympathetic status, and integrating it with big data analytics and machine learning, this system effectively supports clinicians in making more efficient and accurate medical decisions.

  1. Home
  2. SNQ Certified
  3. Certified Services & Products
  4. Hospital
Specialized Medical Services

Skin Sympathetic Activity Predicts ACS

Non-invasive SKNA monitoring decodes signals into precise ACS early warnings, shifting cardiovascular care from reactive treatment to proactive prevention.
Organization
Kaohsiung Medical University Chung-Ho Memorial Hospital
Certification Year
2023、2024、2025
Skin Sympathetic Activity Predicts ACS
Kaohsiung Medical University Chung-Ho Memorial Hospital

Other Certified Items

Personalized Therapy for Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital
>95
<29
Frontalis Orbicularis Oculi Muscle Flap
Kaohsiung Medical University Chung-Ho Memorial Hospital
<9.1
>2,000
Breast Reconstruction
Kaohsiung Medical University Chung-Ho Memorial Hospital
>1,200
100
Blepharoptosis
Kaohsiung Medical University Chung-Ho Memorial Hospital
>2,000
>90
SMA Scoliosis Surgery
Kaohsiung Medical University Chung-Ho Memorial Hospital
>67
<10
Nursing help prevent epidemics, full measures protection by us. Nursing as the axis of comprehensive epidemic prevention and care scheme
Kaohsiung Medical University Chung-Ho Memorial Hospital
61
20
Home Parenteral Nutrition Care
Kaohsiung Medical University Chung-Ho Memorial Hospital
4,965
327,370
Generative Nursing Intelligence
Kaohsiung Medical University Chung-Ho Memorial Hospital
85
80
Fluoroscopic Guidance for Placing a PICC
Kaohsiung Medical University Chung-Ho Memorial Hospital
<0.4
100
Embodying community-led hospice care.
Kaohsiung Medical University Chung-Ho Memorial Hospital
81.7
62.5
Personalized Therapy for Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital
>95
<29
Frontalis Orbicularis Oculi Muscle Flap
Kaohsiung Medical University Chung-Ho Memorial Hospital
<9.1
>2,000